rasagiline has been researched along with Ophthalmoplegia, Progressive Supranuclear in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedet, AL; Gauthier, S; Kang, MS; Massarweh, G; Mathotaarachchi, S; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M; Soucy, JP; Struyfs, H; Therriault, J | 1 |
| Crispin, A; Hensler, M; Lorenzl, S; Nuebling, G; Paul, S; Zwergal, A | 1 |
1 trial(s) available for rasagiline and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy.
Topics: Aged; Area Under Curve; Cognition Disorders; Depression; Disease Progression; Double-Blind Method; Electrocardiography; Executive Function; Female; Follow-Up Studies; Humans; Indans; Male; Mental Status Schedule; Middle Aged; Monoamine Oxidase Inhibitors; Postural Balance; Sensation Disorders; Supranuclear Palsy, Progressive | 2016 |
1 other study(ies) available for rasagiline and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [
Topics: Aged; Aged, 80 and over; Aminopyridines; Benzofurans; Female; Humans; Hydrocarbons, Fluorinated; Indans; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurofibrillary Tangles; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Supranuclear Palsy, Progressive; tau Proteins | 2019 |